[go: up one dir, main page]

GR1005694B - Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων - Google Patents

Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων

Info

Publication number
GR1005694B
GR1005694B GR20050100282A GR20050100282A GR1005694B GR 1005694 B GR1005694 B GR 1005694B GR 20050100282 A GR20050100282 A GR 20050100282A GR 20050100282 A GR20050100282 A GR 20050100282A GR 1005694 B GR1005694 B GR 1005694B
Authority
GR
Greece
Prior art keywords
specific
antiestrogens
tissue
estrogen receptor
ability
Prior art date
Application number
GR20050100282A
Other languages
English (en)
Other versions
GR20050100282A (el
Inventor
Νικολαος Ασημομυτης
Δεσποινα Συριανη
Original Assignee
Αλεξης Μιχαηλ
Σεκερης Κωνσταντινος
Παπαχατζης Δημητριος
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Αλεξης Μιχαηλ, Σεκερης Κωνσταντινος, Παπαχατζης Δημητριος filed Critical Αλεξης Μιχαηλ
Priority to GR20050100282A priority Critical patent/GR1005694B/el
Publication of GR20050100282A publication Critical patent/GR20050100282A/el
Publication of GR1005694B publication Critical patent/GR1005694B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε νέα ανάλογα ιστοειδικών αντιοιστρογόνων, ειδικά για τον άλφα υποδοχέα των οιστρογόνων καθώς επίσης και μεθόδους για την σύνθεση αυτών. Τα νέα αντιοιστρογόνα έχουν την δυνατότητα να δράσουν προληπτικά και θεραπευτικάκατά του καρκίνου του μαστού όπως κρίνεται με βάσητην ικανότητα τους να συνδέονται στους δύο υποδοχείς οιστρογόνων, άλφα (αΥΟ) και βήτα (βΥΟ) και να παρουσιάζουν αντιοιστρογονική και αντινεοπλαστική δράση σε κύτταρα καρκίνου μαστού και ενδομήτριου ανθρώπου, και τέλος με βάση την ασφάλεια τους, όπωςαυτή προκύπτει από την επίδραση που έχουν στο βάρος της μήτρας των προεφηβικών αρουραίων. Η παρούσα εφεύρεση αφορά σε ενώσεις του τύπου (1), όπου ταR προσδιορίζονται στην περιγραφή της εφεύρεσης.
GR20050100282A 2005-06-08 2005-06-08 Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων GR1005694B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20050100282A GR1005694B (el) 2005-06-08 2005-06-08 Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20050100282A GR1005694B (el) 2005-06-08 2005-06-08 Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων

Publications (2)

Publication Number Publication Date
GR20050100282A GR20050100282A (el) 2007-01-19
GR1005694B true GR1005694B (el) 2007-10-22

Family

ID=37560958

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20050100282A GR1005694B (el) 2005-06-08 2005-06-08 Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων

Country Status (1)

Country Link
GR (1) GR1005694B (el)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5484798A (en) * 1994-09-20 1996-01-16 Eli Lilly And Company Benzothiopene compounds, compositions, and method of inhibiting restenosis
US6395755B1 (en) * 1995-03-10 2002-05-28 Eli Lilly And Company Benzothiophene pharmaceutical compounds
US6417199B1 (en) * 1995-03-10 2002-07-09 Eli Lilly And Company 3-benzyl-benzothiophenes
PL328832A1 (en) * 1996-02-22 1999-02-15 Lilly Co Eli Benzothiophenes, pharmaceutic agents and methods
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
CA2214872C (en) * 1996-10-24 2002-01-22 Eli Lilly And Company Benzothiophene compounds, compositions and methods
CA2219070C (en) * 1996-10-30 2007-12-18 Eli Lilly And Company Methods of preventing breast cancer

Also Published As

Publication number Publication date
GR20050100282A (el) 2007-01-19

Similar Documents

Publication Publication Date Title
SV2002000357A (es) Acidos malonamicos y derivados de los mismos como ligandos de receptor tiroideo ref pc10748amag/bb
SG163585A1 (en) Melanocortin receptor ligands
CU20110011A7 (es) Derivados de piridazina como inhibidores de smo
PT1888541E (pt) Compostos de benzo(d)isoxazol-3-il-amina substituídos como analgésicos
BG108495A (en) 5-ht receptor ligands and uses thereof
BRPI0910182B8 (pt) composto de fórmula (i), composição farmacêutica e uso de um composto
HN2012000137A (es) Derivados de 17 - hidroxi - 17 - pentafluoroetil - estra - 4, 9(10) - dien - 11 - arilo, procedimientos para su preparacion y su uso para el tratamiento de enfermedades
MX2009000169A (es) Derivados de purinona como agonistas de hm74a.
IL215026A (en) 1r7zb antagonist, methods and compounds @ which include @ the same
NZ603155A (en) Phospholipid drug analogs
ZA201003221B (en) Tea composition and process for the manufacture thereof
WO2009020470A3 (en) Cgrp receptor antagonists
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
PH12012501098A1 (en) 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
UY31460A1 (es) Procedimiento de preparacion de compuestos morfinicos
MX2009008324A (es) Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
BRPI0509257A (pt) polimorfo cristalino de acetato de bazedoxifeno, composição, processo para preparar um polimorfo e para aumentar a proporção de acetato de bazedoxifeno forma b em uma composição, métodos de tratar um mamìfero, cáncer de mama e uma mulher em pós-menopausa para um ou mais distúrbios vasomotores, de abaixar colesterol e de inibir perda óssea em um mamìfero e uso de um polimorfo
EA200971004A1 (ru) Способ производства модифицированного смектита или содержащего смектит материала, способного впитывать и высвобождать воду обратимым образом
BRPI0511979A (pt) derivados de triazóis substituìdos como antagonistas de oxitocina, composição farmacêutica compreendendo os referidos derivados, bem como uso dos mesmos
GR1005694B (el) Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
UA94100C2 (ru) Способ получения индазолилмочевин, которые угнетают ванилоидные рецепторы подтипа 1 (vr1)
IL205231A0 (en) Amino arylsulfonamide compounds and their use as 5 - ht6 ligands
TW200613317A (en) Steroid prodrugs with androgenic action
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20150105